ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ

Skip to main content

Get a front-row seat to the University of Colorado's next big ideas competing for more than $1M in awards

Get a front-row seat to the University of Colorado's next big ideas competing for more than $1M in awards

Twelve teams of University of Colorado faculty researchers, graduate student innovators and entrepreneurs will compete for more than $1 million in early-stage commercialization grants in this year’sÌýLab Venture Challenge (LVC) Showcases at the Dairy Arts Center. Judges from Venture Partners at ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ entrepreneurial network will hear Shark Tank-style pitches across two nights, one for innovations in physical sciences and another for biosciences.

Ìý

ÌýÌýPhysical Sciences: Wednesday, Oct. 21, 6-8:30 p.m.Ìý
ÌýÌýBiosciences: Thursday, Oct. 22, 6-8:30 p.m.Ìý

ÌýÌýDairy Arts Center, Boulder
ÌýÌýAll Are Welcome — CU Affiliation is Not Required
ÌýÌýTickets Are Free

Add to Calendar:ÌýÌýÌýÌýÌý

Through LVC, top innovators from ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ, Denver and Colorado Springs compete for grants of up to $125,000. LVC supports projects that address a commercial need, have a clear path to a compelling market and have strong scientific support. The LVC grants are funded by theÌý, as well as Venture Partners and the Chancellor’s Innovation Fund.

LVC is run by Venture Partners, one of the university’s commercialization arms and a central resource for researchers who wish to translate their work into impactful business and social ventures. LVC finalists are working and collaborating with Venture Partners on theirÌýpath to commercialization.

“At this early stage, funding is essential, but can be a challenge to obtain," said Joshua Bennett, director of LVC and assistant director of licensing at Venture Partners. “All of these teams have promising innovations ready to launch new businesses. LVC is a unique opportunity for those innovators to receive that vital funding, and we’re proud to work with the State of Colorado to make it happen."

To date, LVC has funded 117 projects through 70 new deep-tech startup companies, which collectively have raised over $691 million in follow-on financing, including Arkana Therapeutics, Mesa Quantum and Forge Nano — ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ's 11th unicorn spinout.

Members of the entrepreneurial and university communities are invited to attend the LVC Showcases to enjoy good food, network and see which teams will walk away with funding for their groundbreaking work.

2026 LVC Finalists

ÌýÌýShowcase Pitch Presenters |ÌýÌýÌýContact for Project Inquiries
Ìý

Physical Sciences Finalists

AI-Accelerated Advanced Battery Materials

Developing a new class of high-energy, beyond-lithium battery active materials made entirely from earth-abundant, domestically sourced elements. By integrating ML/AI with proprietary advanced crystal-structure engineering, their materials enable energy parity with conventional lithium systems at a fraction of the cost. The team has formed a startup, , to bring their innovation to market.

In the News
  • (2026, National Laboratory of the Rockies)

An Autonomous Optical Clock

Ptarmigan is developing the autonomous optical clock, the first clock to eliminate the environmental and calibration constraints that have kept optical clocks bespoke devices. For the first time, optical precision can be manufactured at scale and deployed as network infrastructure for distributed sensing, quantum systems and national security. The team has formed a startup, , to bring their innovation to market.

Intelligent Electronic Skin Transforming Prosthetic Diagnostics

Intelligent liquid-metal electronic skin embedded in prosthetic sockets for real-time pressure mapping. AI-driven analytics learn each patient’s pressure patterns to predict socket issues before they cause pain. This affordable, scalable system gives prosthetists data-driven insights to improve socket fit and daily comfort. The team has formed a startup, RheoSynapse Inc., to bring their innovation to market.

Read More ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ the Science
  • (2021, Research)
  • (2023, npj Flexible Electronics)

Optical Timekeeping Made Portable: The Single-Chip Acoustic-Optoelectronic Oscillator

A chip-scale microwave oscillator that generates exceptionally pure signal tones by circulating energy between sound and light on a single chip. By amplifying the sound waves directly on-chip — with no electronics in the loop — the device targets the signal purity of room-sized precision oscillators in a package small enough for portable radar, navigation and communications.

Practical Post-Quantum Cryptography for Resource-Constrained Networks and Devices

New quantum-resistant algorithms have been developed that prevent quantum computers from breaking the public-key algorithms that secure almost all internet communications. This technology works where these new public-key algorithms do not: low-power IoT devices and limited-bandwidth networks. The team has formed a startup, , to bring their innovation to market.

Tunable 3D-Printed Helmet Liners for Multi-Impact Protection

Reimagined helmet protection with a 3D-printed liner computationally tuned by sport, helmet region and impact type. Its plate-lattice structure is designed to manage repeated hits and severe impacts alike. Peer-reviewed research showed up to 6x greater energy absorption than conventional foams at equal density—performance being translated into next-generation helmet protection. The team has formed a startup, , to bring their innovation to market.

Read More ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ the Science

  • (2024, Advanced Materials Technologies)
  • (2024, Additive Manufacturing)
  • (2024, Advanced Materials)

Biosciences Finalists

AI-Designed Biomaterials for Regenerative Medicine

Cell therapies are grown in Matrigel, an undefined mouse tumor extract that varies lot to lot; every alternative is one formulation sold for every use. Regelife uses machine learning to design the matrix around the cell, turning 18 months of trial and error into one kit. In ALS, the matrix decides whether transplanted neurons survive. Built on Anseth Lab hydrogel chemistry at ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ. The team has formed a startup, , to bring their innovation to market.

A Real-Time Screening Platform for Drugs Targeting Transcription Regulators

RIFT (Real-time In vitro Fluorescent Transcription), developed in the Taatjes Lab at ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ, enables direct visualization of individual drug-target interactions in real time, distinguishing on-target from off-target activity to improve drug screening ahead of clinical trials. The team has formed a startup, , to bring their innovation to market.

Read More ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ the Science
  • (2025, Cell Reports)

EYA Degraders: Releasing the Immune Brake in Triple-Negative Breast Cancer

Triple-negative breast cancer resists immunotherapy because tumor-associated macrophages are reprogrammed to shield it. The team discovered that eliminating a single protein, EYA3, from those macrophages shrinks tumors in mice and draws cancer-killing T cells inward. They are now building bifunctional molecules that destroy EYA3 outright, making immunologically cold tumors treatable. The team has formed a startup, , to bring their innovation to market.

Read More ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ the Science
  • (2024, ChemMedChem)
  • (2026, bioRxiv)

Long-Acting, Non-Opioid Therapy for Chronic Pain

A long-acting non-opioid analgesic that selectively targets CaV3.2 to provide sustained relief from chronic pain without abuse liability. The team has formed a startup, , to bring their innovation to market.

Read More ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ the Science
  • (2025, bioRxiv)

Microgravity Manufacturing of Next-Generation Stem Cell Therapies

A microgravity biomanufacturing platform designed to expand umbilical cord blood stem cells for treating blood cancers. By keeping cells naturally suspended without mechanical agitation, the technology aims to preserve their therapeutic advantages while producing enough cells to treat adult patients, unlocking the potential of cord blood transplantation. The team has formed a startup, Opera Space LLC, to bring their innovation to market.

Novel Electromechanics Biomarkers for Cartilage Health Diagnostics

A noninvasive MRI technique that reveals cartilage's hidden electrical and mechanical signatures under joint loading, detecting early degeneration years before it appears on standard scans. This new biomarker could help diagnose osteoarthritis risk sooner and track whether emerging joint-preserving therapies are actually working. The team has formed a startup, Potentis Imaging, to bring their innovation to market.

The Newsroom

Subscribe to Newsletters

The InsiderÌýisÌýVenture Partners at ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ's monthly newsletter featuring theÌýlatest headlines, news, events, opportunities and emerging innovations from the university. We have several editions for our audiences:

ÌýSubscribe to The InsiderÌýÌý

Media Inquiries

For marketing and communication inquiries or news tips, contact Daniel Leonard,Ìýsenior marketing and communications specialist for Venture Partners at ÃÛÌÒ´«Ã½ÆÆ½â°æÏÂÔØ.

For media inquiries, please visit .

Latest News

Visit the Newsroom